Updates to VTE in Oncology: A Clinical Opportunity for Advanced Practice Pharmacy

Course Experts: Beata Rucinski, PharmD and Jean Connors, MD

Course Description: This course describes the place in therapy of direct oral anticoagulants (DOACs) in cancer associated VTEs and reviews the evidence that influences cancer associated anticoagulation guidelines.

Credits: CEUs will be granted for pharmacists in disease state management/drug therapy.

Venous Thromboembolism (VTE), Anticoagulation, Direct Oral Anticoagulants (DOACs), Collaborative Drug Therapy Management (CDTM), Anticoagulation Management Service (AMS), Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), National Comprehensive Cancer Network (NCCN), Warfarin, Low Molecular Weight Heparin (LMWH), Apixaban, Edoxaban, Rivaroxaban, Dalteparin, Enoxaparin, Thrombocytopenia, Khorana Score, Prophylaxis, Thrombosis, Hokusai